Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.34 |
| ▸ | TSPO | P30536 | 1/20 | 0.32 |
| ▸ | HTR6 | P50406 | 2/20 | 0.31 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.30 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.30 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.30 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.30 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.30 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20009935 | 0.95 | L3MBTL1 (0.41) | KDM4EATML3MBTL1HDAC4TSPO | |
| SCHEMBL20812938 | 0.95 | L3MBTL1 (0.41) | KDM4EATML3MBTL1HDAC4TSPO | |
| SCHEMBL20009775 | 0.94 | L3MBTL1 (0.41) | KDM4EATML3MBTL1HDAC4TSPO | |
| SCHEMBL24947291 | 0.94 | L3MBTL1 (0.41) | KDM4EATML3MBTL1HDAC4TSPO | |
| SCHEMBL24947289 | 0.93 | L3MBTL1 (0.41) | KDM4EATML3MBTL1HDAC4TSPO | |
| SCHEMBL20812988 | 0.92 | KDM4E (0.37) | KDM4EATML3MBTL1HDAC4TSPO | |
| SCHEMBL20009774 | 0.92 | KDM4E (0.37) | KDM4EATML3MBTL1HDAC4TSPO | |
| SCHEMBL20009735 | 0.92 | L3MBTL1 (0.45) | KDM4EATML3MBTL1HDAC4TSPO | |
| SCHEMBL20009888 | 0.91 | KDM4E (0.38) | KDM4EATML3MBTL1HDAC4TSPO | |
| SCHEMBL20009976 | 0.91 | HTR6 (0.33) | KDM4EATML3MBTL1TSPOHTR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10573824-B2 | Compound and organic electronic element comprising same | LG CHEM, LTD. (KR) | 2020-02-25 | — | — | US | disclosed |
| US-20180090688-A1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-03-29 | — | — | US | disclosed |
| US-20180090688-A1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180090688-A1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | OR10J3, ETV6, BMI1 | KDM4E 390/4885ATM 2315/4885L3MBTL1 1563/4885 |
| US-10573824-B2 | Compound and organic electronic element comprising same | OR10J3, ETV6, BMI1 | KDM4E 390/4885ATM 2315/4885L3MBTL1 1563/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.